Fatigue and side effects from CAR-T therapy for lymphoma
Part of Blood & lymphatic, Cancer, Immune system & allergy clinical trials.
This study looks at how fatigue relates to specific side effects in the first month after CAR-T cell treatment for non-Hodgkin's lymphoma. It may help understand and manage fatigue better.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You are being treated with CAR-T cells for non-Hodgkin's lymphoma
- You can understand and read French
- You are not under legal guardianship
- You agree to participate in the research
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new type of CAR-T cell therapy designed to treat certain blood cancers (like leukemia, lymphoma, or multiple myeloma) that have come back or not responded to standard treatment. The cells are enhanced with IL-15 to help them work better.
This trial looks at how muscle loss (sarcopenia) and overall health affect outcomes in people with B-cell lymphoma who are receiving CAR-T cell therapy. It may help doctors better support patients before and after treatment.
This study tests if non-drug approaches like lifestyle changes or supportive care can reduce nerve-related side effects in people with blood cancers who are receiving CAR-T therapy. It aims to help patients feel better during treatment.
This study aims to create models that predict how well patients with non-Hodgkin lymphoma will respond to CAR-T cell therapy and how likely they are to have side effects. It may help doctors tailor treatment for people whose lymphoma has not improved or has come back.
This study looks at how the type of chemotherapy given before CAR T-cell treatment affects how well the CAR T-cells work in people with aggressive large B-cell lymphoma that has come back or not responded to treatment. It aims to find out which pre-treatment approach leads to better outcomes.
This study follows children and young adults who received CAR T cell therapy to understand any long-term side effects that may appear months to years later. By joining, you help researchers learn how to better care for patients after this treatment.
Hear when a new Fatigue Symptom trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.